CTLA-4 correlates with immune and clinical characteristics of glioma

CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients wit...

Source: Cancer Cell International - January 6, 2020 Category: Cancer & Oncology Authors: Fangkun Liu, Jing Huang, Xuming Liu, Quan Cheng, Chengke Luo and Zhixiong Liu Tags: Primary research Source Type: research